Stereoselective synthesis of oxazolidinonyl-fused piperidines of interest as selective muscarinic (M1) receptor agonists: a novel M1 allosteric modulator

被引:4
|
作者
Broadley, Kenneth J. [1 ]
Buffat, Maxime G. P. [2 ]
Burnell, Erica [2 ]
Davies, Robin H. [3 ]
Moreau, Xavier [2 ]
Snee, Stephen [2 ]
Thomas, Eric J. [2 ]
机构
[1] Cardiff Univ, Cardiff Sch Pharm & Pharmaceut Sci, Redwood Bldg,King Edward 7 Ave, Cardiff CF10 3NB, S Glam, Wales
[2] Univ Manchester, Sch Chem, Manchester M13 9PL, Lancs, England
[3] Muscagen Ltd, 10 North Rd, Cardiff CF10 3DY, S Glam, Wales
关键词
1,3 TRANSPOSITION; ALLYLIC AMINES; GENERAL-METHOD; REARRANGEMENT; ALCOHOLS; KETONES; TRIETHYLSILANE; DEOXYGENATION; SECONDARY; REAGENTS;
D O I
10.1039/c5ob02588e
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Syntheses of (1RS,2SR,6SR)-2-alkoxymethyl-, 2-hetaryl-, and 2-(hetarylmethyl)-7-arylmethyl-4,7-diaza-9-oxabicyclo[4.3.0]nonan-8-ones, of interest as potential muscarinic M-1 receptor agonists, are described. A key step in the synthesis of (1RS, 2SR, 6SR)-7-benzyl-6-cyclobutyl-2-methoxymethyl-4,7-diaza-9-oxabicyclo[4.3.0]nonan-8-one, was the addition of isopropenylmagnesium bromide to 2-benzyloxycarbonylamino-3-tert-butyldimethylsilyloxy-2-cyclobutylpropanal. This gave the 4-tert-butyldimethylsilyloxymethyl-4-cyclobutyl-5-isopropenyloxazolidinone with the 5-isopropenyl and 4-tert-butyldimethyl-silyloxymethyl groups cis-disposed about the five-membered ring by chelation controlled addition and in situ cyclisation. This reaction was useful for a range of organometallic reagents. The hydroboration-oxidation of (4SR,5RS)-3-benzyl-4-(tert-butyldimethylsilyloxymethyl)-4-cyclobutyl-5-(1-methoxyprop-2-en-2-yl)-1,3-oxazolidin-2-one gave (4SR, 5RS)-3-benzyl-4-(tert-butyldimethylsilyloxymethyl)-4cyclobutyl-5-[(SR)-1-hydroxy-3-methoxyprop-2-yl]-1,3-oxazolidin-2-one stereoselectively. 4,7-Diaza-9-oxabicyclo[4.3.0] nonan-8-ones with substituents at C2 that could facilitate C2 deprotonation were unstable with respect to oxazolidinone ring-opening and this restricted both the synthetic approach and choice of 2-heteroaryl substituent. The bicyclic system with a 2-furyl substituent at C2 was therefore identified as an important target. The addition of 1-lithio-1-(2-furyl) ethene to 2-benzyloxycarbonylamino-3-tert-butyldimethylsilyloxy-2-cyclobutylpropanal gave (4SR, 5RS)-4-tert-butyldimethylsilyloxymethyl-4-cyclobutyl-5-[1-(2-furyl) ethenyl]-1,3-oxazolidinone after chelation controlled addition and in situ cyclisation. Following oxazolidinone N-benzylation, hydroboration at 35 degrees C, since hydroboration at 0 degrees C was unexpectedly selective for the undesired isomer, followed by oxidation gave a mixture of side-chain epimeric alcohols that were separated after SEM-protection and selective desilylation. Conversion of the neopentylic alcohols into the corresponding primary amines by reductive amination, was followed by N-nosylation, removal of the SEM-groups and cyclisation using a Mitsunobu reaction. Denosylation then gave the 2-furyloxazolidinonyl-fused piperidines, the (1RS, 2SR, 6SR)-epimer showing an allosteric agonistic effect on M-1 receptors. Further studies resulted in the synthesis of other 2-substituted 4,7diaza-9-oxabicyclo[4.3.0] nonan-8-ones and an analogous tetrahydropyran.
引用
收藏
页码:2057 / 2089
页数:33
相关论文
共 50 条
  • [1] Lead optimization of a selective M1 muscarinic receptor positive allosteric modulator
    Kuduk, Scott D.
    Chang, Ronald K.
    Di Marco, Christina N.
    Ray, William J.
    Ma, Lei
    Wittmann, Marion
    Seager, Matthew A.
    Koeplinger, Kenneth A.
    Thompson, Charles D.
    Hartman, George D.
    Bilodeau, Mark T.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [2] Orthosteric and Allosteric Modes of Interaction of Novel Selective Agonists of the M1 Muscarinic Acetylcholine Receptor
    Avlani, Vimesh A.
    Langmead, Christopher J.
    Guida, Elizabeth
    Wood, Martyn D.
    Tehan, Ben G.
    Herdon, Hugh J.
    Watson, Jeannette M.
    Sexton, Patrick M.
    Christopoulos, Arthur
    [J]. MOLECULAR PHARMACOLOGY, 2010, 78 (01) : 94 - 104
  • [3] Novel Fused Arylpyrimidinone Based Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor
    Mistry, Shailesh N.
    Lim, Herman
    Joerg, Manuela
    Capuano, Ben
    Christopoulos, Arthur
    Lane, J. Robert
    Scammells, Peter J.
    [J]. ACS CHEMICAL NEUROSCIENCE, 2016, 7 (05): : 647 - 661
  • [4] A RATIONALE FOR THE DESIGN AND SYNTHESIS OF M1 SELECTIVE MUSCARINIC AGONISTS
    TECLE, H
    LAUFFER, DJ
    MIRZADEGAN, T
    MOOS, WH
    MORELAND, DW
    PAVIA, MR
    SCHWARZ, RD
    DAVIS, RE
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1992, 2 (08) : 821 - 826
  • [5] Synthesis and biochemical activity of novel amidine derivatives as m1 muscarinic receptor agonists
    Ojo, B
    Dunbar, PG
    Durant, GJ
    Nagy, PI
    Huzl, JJ
    Periyasamy, S
    Ngur, DO
    ElAssadi, AA
    Hoss, WP
    Messer, WS
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 1996, 4 (10) : 1605 - 1615
  • [6] Acylhydrazones as M1/M3 selective muscarinic agonists
    Wu, ESC
    Kover, A
    Loch, JT
    Rosenberg, LP
    Semus, SF
    Verhoest, PR
    Gordon, JC
    Machulskis, AC
    McCreedy, SA
    Zongrone, J
    Blosser, JC
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (21) : 2525 - 2530
  • [7] Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation
    Ma, Lei
    Seager, Matthew
    Wittmann, Marion
    Jacobson, Marlene
    Bickel, Denise
    Burno, Maryann
    Jones, Keith
    Graufelds, Valerie Kuzmick
    Xu, Guangping
    Pearson, Michelle
    McCampbell, Alexander
    Gaspar, Renee
    Shughrue, Paul
    Danziger, Andrew
    Regan, Christopher
    Flick, Rose
    Pascarella, Danette
    Garson, Susan
    Doran, Scott
    Kreatsoulas, Constantine
    Veng, Lone
    Lindsley, Craig W.
    Shipe, William
    Kuduk, Scott
    Sur, Cyrille
    Kinney, Gene
    Seabrook, Guy R.
    Ray, William J.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (37) : 15950 - 15955
  • [8] Allosteric muscarinic M1 receptor action of hybrids related to the M1 agonist xanomeline and to tacrine
    Jumpertz, S.
    Fang, L.
    Decker, M.
    Zhang, Y.
    Mohr, K.
    Traenkle, C.
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 : 15 - 15
  • [9] Rapid and efficient synthesis of a novel cholinergic muscarinic M1 receptor positive allosteric modulator using flash chemistry
    Miura, Shotaro
    Fukuda, Koichiro
    Masada, Shinichi
    Usutani, Hirotsugu
    Kanematsu, Makoto
    Cork, David G.
    Kawamoto, Tetsuji
    [J]. ORGANIC & BIOMOLECULAR CHEMISTRY, 2019, 17 (35) : 8166 - 8174
  • [10] A Stereoselective Synthesis of a 3,4,5-Substituted Piperidine of Interest as a Selective Muscarinic (M1) Receptor Agonist
    Broadley, Kenneth J.
    Buffat, Maxime G. P.
    Davies, Robin H.
    Thomas, Eric J.
    [J]. SYNLETT, 2016, 27 (01) : 45 - 50